Ellen Field
Rheumatology · Bethlehem, PANPI 1407823297
Payments from drug & device makers
Across 1,133 payments — averaging $369.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$138K
- Lilly USA, LLC$69K
- Johnson & Johnson$64K
- UCB, Inc.$45K
- Janssen Scientific Affairs, LLC$42K
- United Rheumatology$29K
- plus $33K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 366 | $137,878 |
| Lilly USA, LLC | 137 | $68,586 |
| Johnson & Johnson(2 entities) | 172 | $63,567 |
| UCB, Inc. | 91 | $44,549 |
| Janssen Scientific Affairs, LLC | 38 | $41,694 |
| United Rheumatology | 4 | $28,750 |
| AbbVie | 104 | $16,983 |
| Genentech USA, Inc. | 46 | $12,377 |
| Eli Lilly | 2 | $775 |
| Novartis | 22 | $443 |
| Pfizer | 37 | $436 |
| AstraZeneca(2 entities) | 22 | $424 |
| GSK | 19 | $397 |
| Cumberland Pharmaceuticals, Inc. | 18 | $340 |
| Bristol Myers Squibb | 11 | $149 |
| E.r. Squibb & Sons, L.L.C. | 7 | $126 |
| ANI Pharmaceuticals, Inc. | 5 | $117 |
| Mallinckrodt Hospital Products Inc. | 6 | $116 |
| Sanofi | 1 | $113 |
| Aurinia Pharma U.S., Inc. | 6 | $104 |
| Medexus Pharma, Inc. | 6 | $79 |
| Ferring Pharmaceuticals Inc. | 5 | $75 |
| Fidia Pharma USA Inc. | 2 | $41 |
| Sobi, Inc | 2 | $37 |
| Mallinckrodt Enterprises LLC | 1 | $26 |
| Antares Pharma, Inc. | 1 | $22 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Radius Health, Inc. | 1 | $17 |
How this compares
$418,240 in reported general payments places this provider in the 90th percentile of 351 rheumatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Bethlehem
- Alan KivitzDuncansville$27.1M
- Peter MerkelRadnor$6.3M
- Rohit AggarwalPittsburgh$6.2M
- Alexis Ogdie-BeattyPhiladelphia$5.7M
- Jonathan MinerPhiladelphia$3.8M
- Siamak Moghadam-KiaPittsburgh$1.9M
- Frederick MurphyDuncansville$1.2M
- Gregory EmkeyWyomissing$1.2M
- Alan EpsteinPhiladelphia$1.2M
- Lawrence LeventhalHuntingdon Valley$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.